Altrartis Therapeutics Inc.
New York, NY
Funding event
The round itself, as filedInferred stageSeries A
Sold of offered$11.0M of $11.0M
Filed2026-10-22
Days since filing22
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- Yes
- Date of first sale
- 2026-08-12
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Florian BrandExecutive Officer · Director · Promoter
- Lars Christian WildeDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-11-13UndersubscribedNot flagged$11.0M of $11.0M sold3.1 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · check date not recorded0
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-11-15OrcosaSeries A · $6.0M of $11.5M · Ewing, NJQuietChronicleBioPre-seed · $250K of $1.0M · Menlo Park, CAQuiet
103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.